Lipid nanoparticles production system Micro jet jet mixer

Pharmaceutical production device for lipid nanoparticles microfluidic nano drugs lipid nanoparticles LNPS instrument micro fluidic mixer micro fluidic jet mixer for nano drug manufacturing

Based on the development of mRNA novel coronavirus vaccine, lipid nanoparticles (LNPS) have been proved to be an effective drug delivery method for delivering RNA drugs and vaccines. LNPS are encapsulated with degradable active components, which mimic low-density lipoprotein (LDLs), and are ingested by endogenous pathways. Lipid nanoparticles are pH sensitive and are designed to release their payloads into the cytoplasm. This will be the first large-scale use of nucleic acid lipid nanoparticles in the history of vaccination

Based on the development of mRNA novel coronavirus vaccine, lipid nanoparticles (LNPS) have been proved to be an effective drug delivery method for delivering RNA drugs and vaccines. LNPS are encapsulated with degradable active components, which mimic low-density lipoprotein (LDLs),and are ingested by endogenous pathways.

Lipid nanoparticles are pH sensitive and are designed to release their payloads into the cytoplasm. This will be the first large-scale use of nucleic acid lipid nanoparticles in

the history of vaccination

Micro jet mixing technology has shown excellent performance in small scale and large-scale production of vaccine lipid nanoparticles.

It can provide small desktop devices for R & D users and complete LNPS devices for the pharmaceutical industry. LNPS production system, also known as IJM equipment (micro jet injection mixing), has been designed and optimized to meet customer performance requirements and regulatory requirements. It has been successfully installed and accepted in the clean room (Class C). The system reserves all necessary interfaces for integration into the customer's own PLC (programmable logic controller) system.